945463-94-5Relevant academic research and scientific papers
CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 39, (2017/03/25)
The present invention provides a compound of Formula II: (II) or a pharmaceutically acceptable salt thereof.
CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 18; 18; 49, (2017/03/08)
The present invention provides a compound of Formula II: or a pharmaceutically acceptable salt thereof.
PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS
-
, (2011/09/20)
The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituents are as defined in the claims.
Novel Pyridine Derivatives
-
Page/Page column 13, (2009/01/24)
The invention relates to novel pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents.
PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS
-
Page/Page column 86, (2009/04/25)
The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituants are as defined in the claims.
